Topics

The Medicrea® Group Company Profile

04:40 EDT 23rd October 2019 | BioPortfolio


News Articles [537 Associated News Articles listed on BioPortfolio]

MEDICREA secures FDA approval for TULIP GENESIS solution

MEDICREA has received FDA Clearance for its TULIP GENESIS which completes its UNiD Adaptive Spine Intelligence (ASI) platform technology. MEDICREA aims at digital transformation of spinal surgery thro...

FDA clears Medicrea's Tulip Genesis screw device

Medicrea's Tulip Genesis top-loading screw device received approval from the FDA, completing the company's UNiD adaptive spin -More- 

Medicrea gets 3 US patents for AI spine surgery software platform

Medicrea has obtained three additional US patents for its UNID Adaptive Spine Intelligence software platform, which enables t -More- 

MEDICREA secures new patents to protect its UNiD ASI technology

The company pioneers the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI (Adaptive Spine Intelligence) proprietary...

MEDICREA® Hosts Third Annual User Group Meeting (MAIA) in Lyon, France Followed by Attendance at SRS in Montreal, Canada

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through Artificial Intelligence, predictive...

Medicrea Reports First Quarter 2019 Sales

STRONG GROWTH IN UNID® PATIENT-SPECIFIC SURGERIES IN THE USA: +68% WW SALES INCREASED BY 10% IN Q1 (+6% at constant exchange rate) USA SALE...

MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence,...

MEDICREA® Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI platform technology

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through Artificial Intelligence, predictive...

Drugs and Medications [0 Results]

None

PubMed Articles [1646 Associated PubMed Articles listed on BioPortfolio]

In-group favouritism and out-group discrimination in naturally occurring groups.

We study in-group favouritism and out-group discrimination in a multiplayer dictator game in a naturally occuring group setting. An allocator divides a large sum of money among three groups of around ...

Methylation Landscape of RUNX3 Promoter Region as a Predictive Marker for Th1/Th2 Imbalance in Bronchiolitis.

BACKGROUND The methylation status of RUNX3 promoter region, its impact on RUNX3 gene expression, and Th1/Th2 imbalance are unknown in bronchiolitis. This study aimed to explore the predictors of bronc...

The effects of triptolide on the cellular activity of cryopreserved rat sciatic nerves and nerve regeneration after allotransplantation.

: To investigate the effects of triptolide (T10) on the cellular activity of cryopreserved rat sciatic nerves and nerve regeneration after allotransplantation. : After the optimal T10 concentration wa...

Group conquers efficacy: Preschoolers' imitation under conflict between minimal group membership and behavior efficacy.

Research has found that preschoolers' imitation demonstrates in-group bias and is guided by behavior efficacy. However, little is known about whether children's sensitivity to behavior efficacy affect...

The 2,2-Dimethyl-2-(-nitrophenyl)acetyl (DMNPA) Group: A Novel Protecting Group in Carbohydrate Chemistry.

The 2,2-dimethyl-2-(-nitrophenyl)acetyl (DMNPA) group was introduced to synthetic carbohydrate chemistry as a protecting group (PG) for the first time. Benefiting from a unique chemical structure and ...

Clinical Trials [4892 Associated Clinical Trials listed on BioPortfolio]

Personalized Spine Study Group Registry

As a registry, the primary objective of the study is a data collection initiative. The study will collect clinical and radiographic outcomes of patients implanted with Medicrea's PSR. The ...

O-arm Assessment of Vertebral Movement Using ST2R Technique

The study is quantifying how your back has been corrected using Medicrea's hardware through imaging taken before, during, and after your surgery. Visits include the pre-operative visit, 1 ...

MAC-cbt Group Therapy for Adults With ADHD

The study is developed to validate a new short psychotherapeutic group treatment for adults with ADHD diagnosis. The participants will be treated in a monocentric, parallel group randomize...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Companies [1700 Associated Companies listed on BioPortfolio]

The MEDICREA® Group

Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive c...

The MEDICREA Group

Through the lens of predictive medicine, Medicrea leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical an...

MEDICREA INTERNATIONAL

MEDICREA is a French company fully dedicated to the design of surgical devices for 15 years. Its outstanding knowledge in design and manufacturing is recognised worldwide. The complete range of patent...

The Medicrea® Group

MEDICREA Group

More Information about "The Medicrea® Group" on BioPortfolio

We have published hundreds of The Medicrea® Group news stories on BioPortfolio along with dozens of The Medicrea® Group Clinical Trials and PubMed Articles about The Medicrea® Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Medicrea® Group Companies in our database. You can also find out about relevant The Medicrea® Group Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record